Literature DB >> 8621214

Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity.

T Ikeda1, T Gomi, N Hirawa, J Sakurai, N Yoshikawa.   

Abstract

To access the role of insulin resistance in obesity hypertension, we examined the change of insulin sensitivity after weight loss in 24 obese hypertensive subjects by the euglycemic hyperinsulinemic glucose clamp method. The results of the 4-week calorie-restricted diet were a weight loss of 10.2% (from 74 +/- 12 to 67 +/- 11 kg, P < .01) and a decrease in mean blood pressure of 13.1% (from 124 +/- 7 to 107 +/- 9 mm Hg, P < .01). A decrease in plasma norepinephrine (from 208 +/- 74 to 142 +/- 52 pg/mL, P < .01) was associated with decreases in plasma renin activity (from 1.06 +/- 0.98 to 0.62 +/- 0.63 ng/mL per hour, P < .01) and serum aldosterone (from 70 +/- 28 to 57 +/- 24 pg/mL, P < .05). Glucose infusion rate increased significantly (42.9%), from 809 +/- to 1155 +/- 251 mumol/m2 per minute. The insulin sensitivity index, which is a measure of the glucose infusion rate divided by plasma insulin, increased significantly (42.6%), from 10.8 +/- 3.5 to 15.4 +/- 4.4 (mumol/m2 per minute)/(microU/mL). Stepwise multiple linear regression analysis showed that changes of plasma norepinephrine, insulin sensitivity index, plasma renin activity, and age were significant predictive factors for the change of mean blood pressure after weight loss. These results indicate a distinct relation between an improvement of insulin sensitivity and a decrease in blood pressure after weight loss in obese hypertensive subjects. The decrease in blood pressure after weight loss is probably related to the suppression of sympathetic nervous activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621214     DOI: 10.1161/01.hyp.27.5.1180

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

Review 1.  Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Authors:  Kazuko Masuo
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Treatment of coexisting diabetes and hypertension.

Authors:  N M Kaplan
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

3.  A rare cardiac finding in a morbidly obese patient with severe hypertension.

Authors:  Anna Maria Vittoria Fiore; Giorgia Michela Marinoni; Alessandro Piccione; Maria Adelaide Marini; Monica D'Adamo; Renato Lauro; Paolo Sbraccia
Journal:  Intern Emerg Med       Date:  2010-10-09       Impact factor: 3.397

Review 4.  The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update.

Authors:  Guido Lastra-Gonzalez; Camila Manrique-Acevedo; James R Sowers
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

5.  Body mass index as a predictor of hypertension incidence among initially healthy normotensive women.

Authors:  Sara L Shuger; Xuemei Sui; Timothy S Church; Rebecca A Meriwether; Steven N Blair
Journal:  Am J Hypertens       Date:  2008-04-10       Impact factor: 2.689

6.  Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Hadis Mozaffari; Sakineh Shab-Bidar; Alireza Milajerdi; Kurosh Djafarian
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

7.  Acute and short-term effects of caloric restriction on metabolic profile and brain activation in obese, postmenopausal women.

Authors:  S Jakobsdottir; I C van Nieuwpoort; C C van Bunderen; M B de Ruiter; J W R Twisk; J B Deijen; D J Veltman; M L Drent
Journal:  Int J Obes (Lond)       Date:  2016-05-24       Impact factor: 5.095

8.  Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean mice.

Authors:  Jason M Tanner; Devin T Kearns; Bum Jun Kim; Crystal Sloan; Zhanjun Jia; Tianxin Yang; E Dale Abel; J David Symons
Journal:  Exp Biol Med (Maywood)       Date:  2010-12

9.  Pathophysiological role of leptin in obesity-related hypertension.

Authors:  M Aizawa-Abe; Y Ogawa; H Masuzaki; K Ebihara; N Satoh; H Iwai; N Matsuoka; T Hayashi; K Hosoda; G Inoue; Y Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

10.  Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults: Longitudinal Observation From the Bogalusa Heart Study.

Authors:  Tao Zhang; Huijie Zhang; Shengxu Li; Ying Li; Yaozhong Liu; Camilo Fernandez; Emily Harville; Lydia Bazzano; Jiang He; Wei Chen
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.